• FiniteBanjo@feddit.online
    link
    fedilink
    English
    arrow-up
    3
    arrow-down
    13
    ·
    1 day ago

    The ground-breaking study, funded by Wellcome, carried out a randomised controlled trial of 99 healthcare workers exposed to trauma at work during the Covid-19 pandemic. The results demonstrate huge potential to implement a highly scalable, low intensity, easily accessible digital treatment that could transform how we prevent and treat PTSD for people who have been exposed to trauma worldwide.

    NO.

    NO NO NO. You don’t get to have 9 in 10 dentists promote some gamified healthcare app to the masses, fuck this. This sounds like the BetterHelp Scam 2.0.

    • Aatube@thriv.socialM
      link
      fedilink
      English
      arrow-up
      1
      arrow-down
      1
      ·
      edit-2
      19 hours ago

      how so? this is a method that would work completely offline and without any form of centralization i can imagine

      • FiniteBanjo@feddit.online
        link
        fedilink
        English
        arrow-up
        1
        ·
        edit-2
        16 hours ago

        It’s a study with a very low sample size funded by some corporation and with the intention to normalize “digital treatment” similar to BetterHelp. This has red flags front to back.

        • Aatube@thriv.socialM
          link
          fedilink
          English
          arrow-up
          1
          arrow-down
          1
          ·
          11 hours ago

          how is this digital treatment similar to BetterHelp? how would it possibly be bad in factors other than efficacy, like BetterHelp was due to data nightmares and advertising a different mechanism? this isn’t even online

          99 is a more than enough sample size if your RCT’s Bayes factor is 114 and 15.8 for better efficacy than -control and -regular treatment respectively, which corresponds to “extreme” and “strong evidence” (Lee and Wagenmakers 2013, p. 105; adjusted from Jeffreys, 1961). The Lancet also peer-reviewed the claim “The Bayesian adaptive trial design enabled efficient evaluation with early stopping when convincing evidence was reached (n=99).[2]”

          indeed further testing is needed to establish subgroup effects and improve generalizability but this is already quite promising